Mar. 21, 2017—Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
Sep. 22, 2016—Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.
Feb. 4, 2016—The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.
Nov. 24, 2015—"Messages of Hope: Advances in Prostate Cancer Prevention, Research and Treatment," a free program for prostate cancer survivors, caregivers and health professionals, will be held Friday, Dec. 11, from 9 to 11 a.m. at the Vanderbilt-Ingram Cancer Center.
Nov. 5, 2015—Beginning this week, Vanderbilt men will have a good excuse to ignore their razors and let their facial hair grow. November has been dubbed “Movember,” a time when men are encouraged to grow a moustache to raise funds and awareness for prostate cancer.
Jun. 18, 2015—A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.
Feb. 5, 2015—Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, has received the Urology Care Foundation Research Scholars Award for the study of advanced prostate cancer.
Jan. 29, 2015— Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.”
Jan. 5, 2015—Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.
Oct. 29, 2014—A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.
Apr. 3, 2014—One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.
Mar. 27, 2014—A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found.